Interestingly, higher CD5/CD3G (HR = 0.220, P=0.008), CD5/CD3D (HR = 0.294, P=0.025), and CD5/CD247 (HR = 0.346, P=0.057) expression was associated with improved OS in T-ALL patients (Figure 3(a), left panel). Here, CD3G is linked to acute lymphoblastic leukemia.